Krauß, Sybille
3 results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Publication A novel aurone RNA CAG binder inhibits the huntingtin RNA–protein interactionA novel aurone binder for CAG RNA repeats has been identified from a library of twenty-eight compounds. The ligand inhibits toxic RNA–protein interactions in the Huntington's disease model.Source Type:Article2 - Some of the metrics are blocked by yourconsent settings
Publication Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR(2023); ; ; ;Giorgetti, AlejandroAlfonso‐Prieto, MercedesThe RNA-binding protein human antigen R (HuR) regulates stability, translation, and nucleus-to-cytoplasm shuttling of its target mRNAs. This protein has been progressively recognized as a relevant therapeutic target for several pathologies, like cancer, neurodegeneration, as well as inflammation. Inhibitors of mRNA binding to HuR might thus be beneficial against a variety of diseases. Here, we present the rational identification of structurally novel HuR inhibitors. In particular, by combining chemoinformatic approaches, high-throughput virtual screening, and RNA–protein pulldown assays, we demonstrate that the 4-(2-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)hydrazineyl)benzoate ligand exhibits a dose-dependent HuR inhibition effect in binding experiments. Importantly, the chemical scaffold is new with respect to the currently known HuR inhibitors, opening up a new avenue for the design of pharmaceutical agents targeting this important protein.Source Type:Article - Some of the metrics are blocked by yourconsent settings
Publication The dynamic world of RNA: beyond translation to subcellular localization and function(2024); Krauß, SybilleKeywords: RNA-localization, RNA-transport, alternative polyadenylation, neurodegenerative diseases, zipcodesSource Type:Article2
